TGen interns present work at first annual symposium
The fifth floor of the TGen building buzzed with life one afternoon last month as 60 summer interns presented their research at TGen's first annual student symposium.
Improving the quality of life in Arizona to benefit future generations.
The fifth floor of the TGen building buzzed with life one afternoon last month as 60 summer interns presented their research at TGen's first annual student symposium.
Researchers from the University of Arizona's Bio5 Institute and UA's plant sciences department are part of an international consortium that has successfully deciphered the complete genetic code of the rice plant.
The CardioWest temporary artificial heart, developed by Tucson's University Medical Center, has been used commercially for the first time in the United States. The Cleveland Clinic implanted a CardioWest Temporary Total Artificial Heart about a week ago in a dying man in his '40s, less than one year after the CardioWest became the first artificial heart approved by the Food and Drug Administration.
Hoping to gain national recognition in the biosciences, Scottsdale, Tempe, and Chandler have teamed up to market a 30 mile stretch of research, technology, and manufacturing businesses along the Loop 101 freeway.
Two reports show that Arizona had its strongest venture capital investment quarter since 2002 and, only halfway through the year, has already beaten last year's investment total. The reports also say that Arizona is performing better than the nation, which is experiencing a downturn in venture investment from its 10-quarter high last year.
The consulting team assisting the Governor's commission that is studying the implementation of the Phoenix medical school presented its report at the panel's June 15 meeting.
Bioscience and biotechnology related firms in start-up, early, or growth phases of development are encouraged to apply to present their business to an audience of over 100 investors, bankers, and money managers at the Arizona Angel Investment Conference.
Arizona's presence at the world's largest biotechnology convention continued its annual growth at the June meeting of the Biotechnology Industry Organization (BIO) in Philadelphia. The state commanded a more prominent, visible location in the exhibition hall than in past years, and generated greater foot traffic from national and international bioscience professionals.
Raised in a small logging town outside Vancouver, Canada, Arizona State University law professor Gary Marchant was one of the few students in his high school class to go to college and he just kept going, receiving his Ph.D. in genetics from ASU, a Master of Public Policy from the Kennedy School of Government at Harvard University, and a J.D. from Harvard Law School. Now, he has merged his career-long interests in science and the law to develop the nation's first master's program in biotechnology and genomics law.
To herald a broadened mission and new focus in the Arizona research community, the organization formerly known as the Arizona Disease Control Research Commission is becoming the Arizona Biomedical Research Commission.